The sale of a seventy-nine percent stake in Wellbeing Nutrition to Mumbai-based pharmaceutical major USV for ₹1,583 crore is not a founder exit, but a strategic move to scale within a pharmaceutical ecosystem, according to Founder and CEO Avnish Chhabria. Chhabria emphasized that the partnership represents validation from mainstream pharma.
“Not a Cash-Out, But a Strategic Scale-Up”
Chhabria said the deal marks a long-term growth collaboration rather than an exit. “This is not us cashing out. This is an entrance into a world that traditionally did not take nutraceutical brands seriously.” He continues to hold 15% stake in the company, while the remaining 6% is held by Co-founder Saurabh Kapoor and ESOP holders. According to Chhabria, the leadership team remains fully committed to scaling Wellbeing Nutrition within the USV ecosystem.
USV Expands into Preventive and Lifestyle Healthcare
With this acquisition, USV — a leading player in India’s oral anti-diabetes and cardiac segments — expands beyond chronic therapies into the fast-growing preventive and lifestyle healthcare space. The move reflects a broader shift in India’s pharmaceutical landscape, where established drugmakers are increasingly exploring wellness and nutraceutical brands to diversify portfolios and tap into rising consumer health awareness.
Strong Revenue Growth and Profitability Roadmap
Founded in 2019, Wellbeing Nutrition has scaled rapidly. The company expects to close FY26 with revenue of approximately ₹263 crore, up sharply from ₹112 crore in the previous year. Looking ahead, it is targeting ₹450 crore in revenue next year, signaling aggressive growth plans under the new partnership. Importantly, nearly 15% of its revenue comes from prescription and hospital channels — a rare distinction in the largely D2C-driven nutraceutical market. This pharma-style distribution approach strengthens its credibility and medical acceptance. Chhabria also highlighted that the company is unit-economics positive and expects to turn fully profitable over the next year.
R&D-Driven Premium Positioning
Operating in the premium segment, Wellbeing Nutrition maintains an average order value of around ₹2,500. It follows an omnichannel strategy, combining direct-to-consumer (D2C), pharmacy sales, and modern trade distribution. The company currently has a presence in over 6,500 retail outlets across India. At the same time, it has begun expanding internationally, particularly in West Asia and Europe. To strengthen product differentiation, Wellbeing Nutrition has invested over ₹60 crore in research and development.
The investment has enabled the development of proprietary delivery formats such as:
*Oral thin strips
*Delayed-release capsules
Such innovations position the brand at the intersection of science-backed nutrition and consumer convenience.
Rising Consolidation in Consumer Health
The transaction underscores increasing consolidation in India’s consumer health and wellness market. As growth in preventive healthcare accelerates, traditional pharmaceutical companies are actively acquiring high-growth nutraceutical brands to capture emerging demand. As reported by thehindubusinessline.com, for Wellbeing Nutrition, the partnership with USV signals more than capital infusion — it represents pharma validation, distribution strength, and a platform for sustained long-term growth.
